POLYMEDNSEPoly Medicure Limited· PharmaceuticalsLowNeutral
Announced Wed, 20 May · 11:24 IST

Intimation of Investors/Analysts Call for the Audited Financial Results for the quarter and year ended 31st March, 2026.

POLYMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+7.4%1-day move
₹1452.00
prior close
₹1478.40
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.1+0.6+0.1+7.4+10.2+4.7-1.0-8.7-8.7+2.3+15.7+17.8
Up moveDown movePending
AI summary

Poly Medicure Limited has announced an earnings conference call scheduled for Monday, 25th May, 2026 at 5:00 PM India time. The call will discuss the audited financial results for Q4FY26 and the full year ended 31st March, 2026. The call will be hosted by Managing Director Himanshu Baid, CFO Naresh Vijayvergiya, and President-Strategy & Corporate Development Rahul Gautam. Dial-in details and coordinator contact information have been provided for investor participation. This intimation complies with SEBI Listing Regulations.

Likely market impact

This is a routine regulatory intimation announcing an earnings call; the actual financial results and their implications for shareholders will only be known after the call takes place on 25th May, 2026.